Blood cancers, Cell type, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial was looking at a short course of chemotherapy with a new drug called Zevalin for people over 60 years of age with diffuse large B cell non Hodgkin lymphoma.
Recruitment start: 1 October 2005
Recruitment end: 3 September 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tim Illidge
Experimental Cancer Medicine Centre (ECMC)
The Christie NHS Foundation Trust
Last reviewed: 12 August 2014
CRUK internal database number: 726